História
1 Mar 2005
GlaxoSmithKline, AstraZeneca, Merck, Pfizer & other firms join UK govt. in committing to increased access to essential medicines for poorest countries, including via differential pricing
See all tags
See all tags
Abbott Laboratories
AstraZeneca
Amgen
Bristol-Myers Squibb
Chiron
Eli Lilly
GlaxoSmithKline
Johnson & Johnson
Merck
Merck Sharp & Dohme (part of Merck)
Novartis
Pfizer
Procter & Gamble
Roche
Ranbaxy Laboratories
Schering-Plough
Shire
Tibotec (part of Johnson & Johnson)
Wyeth (part of Pfizer)
Janssen Pharmaceutica (part of Johnson & Johnson)
Acesso a medicamentos
Enfermidades
Proprietade Intelectual
Reputação
Diretrizes da OCDE
Diretrizes preparadas pelo Governo
G7
Organização Mundial da Saúde (OMS)
União Europeia & Parlamento Europeu
Banco Mundial
Organização Mundial do Comércio (OMC)
Personal Health
Trade
Company Reporting
Company Support for Initiatives Promoting Development, Economic and Social Rights